Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28304615 | 0.73 | — | — | |
| SCHEMBL1726899 | 0.69 | — | — | |
| Pivalate SCHEMBL27882884 | 0.69 | ALDH1A1 (0.44) | ALDH1A1TSHRL3MBTL1 | |
| Benzene SCHEMBL9706847 | 0.69 | SMN1; SMN2 (0.38) | ALDH1A1TSHR | |
| Ammonia Solution, Strong SCHEMBL4593126 | 0.67 | MAPT (0.31) | ALDH1A1 | |
| SCHEMBL9244267 | 0.67 | — | — | |
| SCHEMBL27847630 | 0.67 | MAPT (0.31) | ALDH1A1 | |
| SCHEMBL28609557 | 0.67 | — | — | |
| SCHEMBL27957123 | 0.67 | — | — | |
| Pivalate SCHEMBL28392338 | 0.66 | ALDH1A1 (0.47) | ALDH1A1TSHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210094919-A1 | KRAS MUTANT PROTEIN INHIBITORS | JACOBIO PHARMACEUTICALS CO., LTD. | 2021-04-01 | — | — | US | disclosed |
| WO-2021057832-A1 | KRAS MUTANT PROTEIN INHIBITOR | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2021-04-01 | — | — | WO | disclosed |
| CN-103483231-B | Method for synthesizing alliin with optical activity and reaction device thereof | UNIV JINAN | 2015-07-08 | — | — | CN | disclosed |
| US-8785167-B2 | Biocompatible article for the treatment of water and production of energy | THE JOHNS HOPKINS UNIVERSITY (US) | 2014-07-22 | — | — | US | disclosed |
| CN-103483231-A | Method for synthesizing alliin with optical activity and reaction device thereof | UNIV JINAN | 2014-01-01 | — | — | CN | disclosed |
| CN-101669617-B | Natural beef flavor | TIANJIN CHUNFA BIO TECH GROUP | 2012-10-03 | — | — | CN | disclosed |
| US-20110294159-A1 | Biocompatible Article for the Treatment of Water and Production of Energy | JOHNS HOPKINS UNIVERSITY | 2011-12-01 | — | — | US | disclosed |
| CN-101669617-A | Natural beef flavor | TIANJIN CHUNFA FOOD ADDITIVES | 2010-03-17 | — | — | CN | disclosed |
| CN-1789414-A | Immobilized microorganism for biomass fermentation and hydrogen production and preparation method thereof | UNIV YUNNAN NORMAL (CN) | 2006-06-21 | — | — | CN | disclosed |
| CN-1699337-A | Ambroxol cysteine analogs and their preparation process and use thereof | JIANGSU HANSOH PHARMACEUTICAL (CN) | 2005-11-23 | — | — | CN | disclosed |
| CN-1546042-A | Freeze dried preparation of diammonium glycyrrhizinate and its preparation | 天津市资福医药科技开发有限公司 | 2004-11-17 | — | — | CN | disclosed |
| CN-1544036-A | Speckle removing and whitening traditional medicinal healthy product and its preparation | 刘贤英 | 2004-11-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210094919-A1 | KRAS MUTANT PROTEIN INHIBITORS | KRAS, NRAS, APC | ALDH1A1 4345/4885TSHR 4140/4885L3MBTL1 1760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.